This study demonstrated the role of IL-6 in regulating ultradian activity (shorter cycles that occur several times throughout the day), rest rhythmicity, and clock gene expression, which may contribute to CRDs in some neurodegenerative diseases, including AD. This evidence concerns the gene CLOCK and Alzheimer disease.